Search Results 2031-2040 of 21371 for anti-TNF drugs

1. Pancreatic neuroendocrine tumors - Symptoms and causes - Mayo Clinic

   Pancreatic neuroendocrine tumors (islet cell tumors) treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/pancreatic/ ...

2. Estradiol And Norethindrone (Transdermal Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Combipatch. Canadian Brand Name. Estalis ...

3. Fezolinetant (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

4. Rituximab-Arrx (Intravenous Route) Precautions - Mayo Clinic

   Use an effective form of birth control to keep from getting pregnant during treatment with this medicine and for at least 12 months after the last dose. If you ...

5. PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS - Mayo Clinic

   ... (anti-EGFR). - Active autoimmune disease requiring systemic immunosuppressive therapy (i.e. >10mg of prednisone daily or equivalent). - Participant, who in ...

6. Polymyxin B And Trimethoprim (Ophthalmic Route) Description and Brand Names - Mayo Clinic

   Polymyxin B and trimethoprim belong to the class of medicines known as antibiotics. They work by killing the bacteria or preventing their growth. This medicine ...

7. A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients with Advanced Angiosarcoma (TAPPAS) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Anti-hypertensives may be started prior to randomization.

8. A Study to Evaluate the Safety and Effectiveness of Metformin and Nelfinavir with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Any of the following recent prior anti-myeloma therapy: Alkylators (e.g., melaphalan, cyclophosphamide) and anthracyclines ≤ 14 days prior to registration ...

9. Soft Tissue Tumor Clinical Trials - Mayo Clinic Research

   The antibody is used to recognize tumor cells so the anti-cancer drug can kill them. Factors Contributing to Delay in Diagnosis of Bone/Soft Tissue Sarcoma ...

10. Pulmonary Fibrosis Clinical Trials - Mayo Clinic Research

    The primary purpose of this study is to see how GLPG1690 works together with current standard treatment on lung function and IPF disease in general. The study ...